Choose language
Do you want to set the chosen language as default?
Yes, set as default
This asset is no longer available for investment.
View all assets

Price

$ -

return (12m)

0.00% Logo

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%
graph

price AGRX

AGRX
If you had invested
If you had invested
years ago
7 days
30 days
6 months
YTD
1 year
5 years
10 years
ago, you would now have *
ago, you would now have:
*
*The figure considers the reinvestment of dividends.

Return of AGRX

1 month
3 months
1 year
2 years
5 years
10 years
return
1 month
0.00%
3 months
0.00%
1 year
0.00%
2 years
0.00%
5 years
0.00%
10 years
0.00%
Estatistica

Fundamentals AGRX

review the fundamentals of Agile Therapeutics shares

P/E

0.00
Sector: -2.18 Industry: -0.64

P/SALES RATIO (PSR)

-
Sector: 2.07 Industry: 2.57

P/BV

0.00
Sector: 2.26 Industry: 2.40

DIVIDEND YIELD (DY)

0.00%
Sector: - Industry: -

ROA

-106.00%
Sector: -27.14% Industry: -25.02%

ROE

72.38%
Sector: -30.12% Industry: -30.75%

ROIC

-598.26%
Sector: -416.26% Industry: -73.59%

NET MARGIN

-73.51%
Sector: -28.13% Industry: -29.36%

GROSS MARGIN

63.62%
Sector: 44.11% Industry: 50.73%

OPERATING MARGIN

-62.86%
Sector: -24.26% Industry: -25.70%

P/EBITDA

-
Sector: -0.33 Industry: 1.54

P/EBIT

-
Sector: -2.50 Industry: -0.92

P/ASSET

-
Sector: 1.24 Industry: 1.32

BVPS

-3.13
Sector: 3.37 Industry: 4.47

EPS

-2.27
Sector: -0.90 Industry: -0.87

EQUITY RATIO

-1.46
Sector: 0.43 Industry: 0.45

CAGR REVENUE 5 YEARS

95.83%
Sector: - Industry: -

CAGR PROFIT 5 YEARS

-21.10%
Sector: - Industry: -
statistics

Fundamentals AGRX

Buy And Hold Investor Checklist

Agile Therapeutics Buy And Hold Investor Checklist

This checklist is for informational purposes only and does not constitute investment advice or a recommendation. The score is based on current market parameters and does not guarantee future performance. [Learn how the scoring system works.]

Stock Comparison Tool

graph

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.
Price

AGRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY

Logo Agile Therapeutics

Agile Therapeutics Inc.

Average user rating I10

4.0 (4 people)

United States

United States

28 years

Founded: 1997

2014

Time since IPO - 11 years

28

Employees

Market cap

$ -

$ -

Net worth

$ -21.91 Millions

US$ -21,910,000.00

Assets

$ 14.96 Millions

US$ 14,960,000.00

Total Shares Outstanding

7.00 Millions

7,000,000

Average Daily Trading Volume

$ -

US$ -

Sector

Health

Industry

Pharmaceutical Products

Shares

AGRX
receitas e lucros

AGRX revenue and profits

graph

PROFIT X PRICE AGRX

resultados

Financial Results AGRX

DRAG THE FRAME TO SEE MORE DATA
Resultados

AGRX cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

asset growth - AGRX

Pontos Relevantes

AGRX balance sheet

DRAG THE FRAME TO SEE MORE DATA
Discover more stocks
Logo 4D pharma

LBPSW - 4D pharma

$ - -0,00% (12M)
P/E

0.00

DY

0.00%

ROE

-300.00%

P/BV

0.00
Logo CVS Health

CVS - CVS Health

$ 77.79 82,86% (12M)
P/E

214.89

DY

3.35%

ROE

0.64%

P/BV

1.38
Logo Cigna

CI - Cigna

$ 274.00 0,98% (12M)
P/E

11.89

DY

2.16%

ROE

14.63%

P/BV

1.74
Logo Centene

CNC - Centene

$ 39.22 --34,17% (12M)
P/E

-3.79

DY

0.00%

ROE

-25.12%

P/BV

0.95
Logo Humana

HUM - Humana

$ 260.67 7,33% (12M)
P/E

24.95

DY

1.32%

ROE

6.95%

P/BV

1.73
Logo Sanofi

SNY - Sanofi

$ 47.99 5,04% (12M)
P/E

10.59

DY

4.54%

ROE

13.90%

P/BV

1.47
Logo HCA Healthcare

HCA - HCA Healthcare

$ 466.56 55,22% (12M)
P/E

17.80

DY

0.58%

ROE

-293.84%

P/BV

-52.32
Logo Eli Lilly

LLY - Eli Lilly

$ 1,056.88 33,93% (12M)
P/E

50.06

DY

0.58%

ROE

77.20%

P/BV

38.64
Logo 4D pharma

LBPSW - 4D pharma

$ - -0,00% (12 M)
P/L

0.00

DY

0.00%

ROE

-300.00%

P/VP

0.00
Logo CVS Health

CVS - CVS Health

$ 77.79 82,86% (12 M)
P/L

214.89

DY

3.35%

ROE

0.64%

P/VP

1.38
Logo Cigna

CI - Cigna

$ 274.00 0,98% (12 M)
P/L

11.89

DY

2.16%

ROE

14.63%

P/VP

1.74
Logo Centene

CNC - Centene

$ 39.22 --34,17% (12 M)
P/L

-3.79

DY

0.00%

ROE

-25.12%

P/VP

0.95
Logo Humana

HUM - Humana

$ 260.67 7,33% (12 M)
P/L

24.95

DY

1.32%

ROE

6.95%

P/VP

1.73
Logo Sanofi

SNY - Sanofi

$ 47.99 5,04% (12 M)
P/L

10.59

DY

4.54%

ROE

13.90%

P/VP

1.47
Logo HCA Healthcare

HCA - HCA Healthcare

$ 466.56 55,22% (12 M)
P/L

17.80

DY

0.58%

ROE

-293.84%

P/VP

-52.32
Logo Eli Lilly

LLY - Eli Lilly

$ 1,056.88 33,93% (12 M)
P/L

50.06

DY

0.58%

ROE

77.20%

P/VP

38.64

Frequently Asked Questions

What is the price of Agile Therapeutics (AGRX) today?

The price of Agile Therapeutics (AGRX) today is $ 0.00, with return of 0% compared to the last year. The price of Agile Therapeutics (AGRX) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Agile Therapeutics (AGRX) and international markets.

When does Agile Therapeutics (AGRX) pay dividends?

Agile Therapeutics (AGRX) did not distribute dividends in the last year.

Is Agile Therapeutics (AGRX) worth it?

Currently, Agile Therapeutics (AGRX) is priced at $ 0.00, with a P/E of 0.00%, representing a deviation of 0% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Agile Therapeutics (AGRX) stock?

Investing in stocks of Agile Therapeutics (AGRX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Agile Therapeutics (AGRX) yield today?

The yield of Agile Therapeutics (AGRX) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Agile Therapeutics (AGRX) today, the total investment would be $ 0.00, based on the current price of $ 0.00.

If past performance were to repeat, the return on your investment would be:

  • In 1 year: $ 0.00
  • In 5 years: $ 0.00
  • In 10 years: $ 0.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.